Evidence map›Paper›PMID 41582640›Full record

ArticleDevelopment (Cambridge, England)2026

Kindlins regulate integrin- and growth factor-dependent ureteric bud formation.

Shensen Li, Fabian Bock, Olga Viquez, Anjana Hassan, Sijo Mathew, Riya Palamuttam, Glenda Mernaugh, Xinyu Dong, Meiling Melzer, Matthew Tantengco and 5 more

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Shensen LiDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Fabian BockDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.ORCID 0000-0002-0788-2945
Olga ViquezDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Anjana HassanDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Sijo MathewDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Riya PalamuttamDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Glenda MernaughDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Xinyu DongDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Meiling MelzerDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Matthew TantengcoDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Thomas CarrollDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Andrew TerkerDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.ORCID 0000-0003-1498-9043
Juan Pablo ArroyoDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.ORCID 0009-0004-1113-1695
Ambra PozziDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Roy ZentDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.ORCID 0000-0003-2983-8133

Funding

Innovative therapeutic approaches to treat chronic kidney diseaseDP5OD033412 · OD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TERKER, ANDREW S. · 2022 to 2025
$2.2M
Matrix receptors in chronic kidney diseaseR01DK119212 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BORZA, CORINA MARILENA, POZZI, AMBRA · 2018 to 2022
$1.7M
Rac1 and the actin cytoskeleton in renal tubular repairK08DK134879 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Fabian Maximilian Bock · 2023 to 2026
$636k
BLRD VA IK6 BX005240Kidney CureNIDDK NIH HHS DK069921NIDDK NIH HHS DK088327NIDDK NIH HHS DK119212NIDDK NIH HHS DK127589NIDDK NIH HHS DK134879NIH HHS DK069921NIH HHS DK088327NIH HHS DK127589NIH HHS DP5 OD033412NIH HHS K08 DK134879NIH HHS R01 DK119212Southern Society for Clinical InvestigationU.S. Department of Veterans Affairs 1I01BX002025U.S. Department of Veterans Affairs I01-BX002196Vanderbilt UniversityW.M. Keck Foundation
6 · The paper itself

Abstract

The kidney collecting system develops from the ureteric bud (UB), which undergoes multiple rounds of iterative branching. This process is controlled by growth factors and requires the interaction between the extracellular matrix and β1-containing integrin receptors. Integrin affinity for its ligands is regulated by integrin-binding proteins including kindlins, which bind well-defined motifs within the β subunit cytoplasmic tail. We show that mice expressing β1 integrins with mutations that abrogate kindlin binding in the developing UB have mild medullary hypoplasia and a moderate branching defect. Collecting duct (CD) cells expressing the same mutations in the β1 subunit have moderate tubulogenesis, spreading and adhesion defects, but show intact growth factor-dependent signaling. In contrast, mice lacking kindlins in the UB are anephric due to a complete absence of UB budding. Kindlin-knockout CD cells are unable to spread, adhere or respond to growth factors, irrespective of whether the integrins are bound to a ligand. Thus, in addition to regulating integrin function, kindlins mediate crucial growth factor signaling required for initial UB formation.

Indexed as

Cytoskeletal ProteinsIntegrin beta1IntegrinsIntercellular Signaling Peptides and ProteinsUreterAnimalsCell AdhesionEmbryonic StructuresKidneyKidney Tubules, CollectingMiceMice, KnockoutMuscle ProteinsSignal TransductionCytoskeletal ProteinsIntegrin beta1IntegrinsIntercellular Signaling Peptides and Proteinskindlin-2 protein, mouseMuscle ProteinsBranching morphogenesisGrowth factorIntegrinsKidney developmentKindlins

Identifiers

PMID41582640
PMCPMC12951293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.